They evaluated the use of concomitant drugs that may potentially affect the thyroid gland, such as ACE inhibitors and beta blockers; however, there was no evaluation of insulin resistance, hyperglycemia, obesity, or hypertension. Here, ACE is linked to obesity disorder.